COM:MARKERTHERAPEUTICS
Marker Therapeutics
- Stock
Last Close
2.97
22/11 21:00
Market Cap
44.42M
Beta: -
Volume Today
11.73K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -5.53M - | -30.88M 458.21% | -34.07M 10.31% | -2.46M 92.79% | -10.98M 347.27% | -147.96M 1,247.25% | -21.43M 85.52% | -28.71M 33.97% | -41.88M 45.89% | -29.93M 28.53% | -14.05M 53.07% | |
depreciation and amortization | 286.58K - | 1.08M 275.35% | 3.16M 194.01% | 3.68M 16.37% | ||||||||
deferred income tax | -7.15M - | |||||||||||
stock based compensation | 132.09K - | 1.39M 953.14% | 1.71M 22.57% | 1.56M 8.60% | 2.74M 75.71% | 16.35M 497.12% | 5.36M 67.24% | 5.23M 2.40% | 5.96M 14.07% | 5.34M 10.40% | 858.27K 83.94% | |
change in working capital | 2.58M - | -212.70K 108.24% | 109.72K 151.58% | 256.24K 133.54% | 302.37K 18.00% | 1.04M 244.78% | -2.48M 338.07% | 3.57M 243.98% | 5.47M 53.15% | -5.81M 206.23% | 2.85M 148.97% | |
accounts receivables | 51.99K - | 55.63K 7.01% | 1.00M 1,698.17% | -2.40M 340.10% | 1.37M 157.22% | |||||||
inventory | -51.99K - | -55.63K 7.01% | -1.00M 1,698.17% | 2.40M 340.10% | ||||||||
accounts payables | 2.48M - | -145.20K 105.85% | 96.02K 166.13% | 257.58K 168.26% | 283.37K 10.01% | 1.24M 338.03% | -963.97K 177.66% | 4.22M 538.03% | 4.14M 1.92% | -4.30M 203.85% | 611.26K 114.21% | |
other working capital | 100.38K - | -67.50K 167.24% | 13.70K 120.30% | -1.35K 109.82% | 19.00K 1,511.52% | -198.74K 1,146.08% | -1.52M 663.75% | -649.12K 57.24% | 1.33M 305.05% | -1.51M 213.62% | 861.11K 156.94% | |
other non cash items | 2.12M - | 27.52M 1,195.17% | 27.91M 1.42% | -5.87M 121.03% | -497.87K 91.52% | 116.08M 23,416.54% | -18K 100.02% | -31K 72.22% | 7.15M 23,156.74% | -252.69K 103.54% | -6.10M 2,313.63% | |
net cash provided by operating activities | -694.58K - | -2.19M 214.89% | -4.34M 98.59% | -6.51M 49.88% | -8.44M 29.64% | -14.48M 71.57% | -18.28M 26.27% | -18.86M 3.15% | -27.28M 44.65% | -26.97M 1.13% | -16.44M 39.05% | |
investments in property plant and equipment | -147.67K - | -374.98K 153.94% | -10.43M 2,680.91% | -3.13M 69.97% | -4.95M 57.93% | |||||||
acquisitions net | ||||||||||||
purchases of investments | ||||||||||||
sales maturities of investments | ||||||||||||
other investing activites | 18.66M - | |||||||||||
net cash used for investing activites | -147.67K - | -374.98K 153.94% | -10.43M 2,680.91% | -3.13M 69.97% | -4.95M 57.93% | 18.66M 477.42% | ||||||
debt repayment | -20K - | -15K 25% | -48K - | -185.18K - | -173.27K 6.43% | -388.79K 124.39% | -513.89K 32.18% | |||||
common stock issued | 1.88M - | 2.33M 23.89% | 3.14M 34.79% | 5.41M 72.50% | 66.94M 1,137.81% | 816.48K 98.78% | 6.19M 657.65% | 52.55M 749.54% | 202.13K 99.62% | 1.11M 446.74% | ||
common stock repurchased | -310.49K - | -71.71K 76.90% | ||||||||||
dividends paid | ||||||||||||
other financing activites | 729.33K - | 418K 42.69% | 8.45M 1,922.01% | 4.70M 44.42% | 619.62K 86.81% | 4.37M 605.55% | 185.18K 95.76% | 723.27K 290.58% | 391.88K 45.82% | 513.89K 31.14% | ||
net cash used provided by financing activities | 709.33K - | 2.28M 221.50% | 10.78M 372.62% | 7.78M 27.77% | 5.72M 26.55% | 71.25M 1,146.09% | 816.48K 98.85% | 6.74M 725.01% | 52.56M 680.22% | 202.13K 99.62% | 1.11M 446.74% | |
effect of forex changes on cash | -6.10M - | |||||||||||
net change in cash | 14.75K - | 93.36K 532.92% | 6.43M 6,792.64% | 1.27M 80.19% | -2.72M 313.54% | 56.62M 2,180.03% | -17.84M 131.51% | -22.55M 26.39% | 22.14M 198.20% | -31.72M 243.22% | 3.33M 110.50% | |
cash at beginning of period | 33.84K - | 48.59K 43.59% | 141.94K 192.13% | 6.58M 4,533.21% | 7.85M 19.38% | 5.13M 34.67% | 61.75M 1,103.81% | 43.90M 28.90% | 21.35M 51.37% | 43.50M 103.71% | 11.78M 72.91% | |
cash at end of period | 48.59K - | 141.94K 192.13% | 6.58M 4,533.21% | 7.85M 19.38% | 5.13M 34.67% | 61.75M 1,103.81% | 43.90M 28.90% | 21.35M 51.37% | 43.50M 103.71% | 11.78M 72.91% | 15.11M 28.26% | |
operating cash flow | -694.58K - | -2.19M 214.89% | -4.34M 98.59% | -6.51M 49.88% | -8.44M 29.64% | -14.48M 71.57% | -18.28M 26.27% | -18.86M 3.15% | -27.28M 44.65% | -26.97M 1.13% | -16.44M 39.05% | |
capital expenditure | -147.67K - | -374.98K 153.94% | -10.43M 2,680.91% | -3.13M 69.97% | -4.95M 57.93% | |||||||
free cash flow | -694.58K - | -2.19M 214.89% | -4.34M 98.59% | -6.51M 49.88% | -8.44M 29.64% | -14.63M 73.32% | -18.66M 27.56% | -29.29M 56.96% | -30.41M 3.84% | -31.92M 4.95% | -16.44M 48.49% |
All numbers in (except ratios and percentages)